首页> 外文期刊>Practical Laboratory Medicine >Customisation and validation of a low-volume plasma renin activity immunoassay: Enabling of regulatory compliant determination in paediatric trials
【24h】

Customisation and validation of a low-volume plasma renin activity immunoassay: Enabling of regulatory compliant determination in paediatric trials

机译:小剂量血浆肾素活性免疫测定的定制和验证:在儿科试验中启用符合法规的测定

获取原文
       

摘要

ObjectivesInvestigations of plasma renin activity (PRA) in children are urgently required. Small-volume, regulatory guideline compliant, bioanalytical assays tailored for paediatric application could facilitate to overcome this hurdle. Ethical constraints given e.g. by the European Medicines Agency need to be addressed and reliable data generation in line with Good Clinical Laboratory Practice must be ensured.MethodsA PRA enzyme-linked immunosorbent assay (ELISA) was tailored for paediatric application and validated in the context of the U.S. Food and Drug Administration bioanalytical guideline. Performance verification of the assay was conducted by participation in an interlaboratory ring test, evaluation of incurred sample reanalysis and an application-orientated approach in children.ResultsA five-fold reduction of required plasma volume to 100?μL was achieved without limiting the calibration range. Between-run accuracy and precision varied no more than 5.0% and 6.3%, respectively. No substantial matrix effect was detected and the inter-run precision for parallelism was 11.1%. Stability experiments approved the freeze-thaw stability, short-term stability as well as 37 weeks of long-term stability. The assay successfully participated in the interlaboratory ring test, showing non-inferiority regarding radioimmunoassay (RIA). Moreover, PRA in plasma samples of neonates was successfully determined. Conducted incurred sample reanalysis confirmed the comparability and reliability of the assay with regard to international regulatory bioanalytical guidelines.ConclusionA fit-for-purpose PRA ELISA characterised by low-volume application was successfully established, indicating non-inferiority regarding commonly applied RIAs. Reliability of the regulatory-compliant PRA assay was proven by participation in an interlaboratory ring test and its application in a paediatric population.
机译:目的迫切需要调查儿童血浆肾素活性(PRA)。专为儿科应用量身定制的小批量,符合法规要求的生物分析测定方法,可以帮助克服这一障碍。道德约束例如需要解决欧洲药品管理局(European Medicines Agency)的问题,并且必须确保符合“良好临床实验室操作规范(Good Clinical Laboratory Practice)”的可靠数据产生。管理生物分析指南。通过参加实验室间环试验,评估发生的样品再分析和针对儿童的应用导向方法进行了测定的性能验证。结果在不限制校正范围的情况下,所需血浆量减少了五倍,达到100 µL。批间精度和精度的差异分别不超过5.0%和6.3%。没有检测到明显的基质效应,并且并行度的内部运行精度为11.1%。稳定性实验批准了冻融稳定性,短期稳定性以及37周的长期稳定性。该测定法成功地参加了实验室间环试验,显示出放射免疫测定法(RIA)的非劣效性。此外,成功测定了新生儿血浆样品中的PRA。进行的样品再分析证实了该测定与国际法规生物分析准则的可比性和可靠性。结论成功建立了以小批量应用为特征的适合用途的PRA ELISA,表明对于常用的RIA而言不逊色。通过参与实验室间环试验及其在儿科人群中的应用,证明了符合法规要求的PRA分析的可靠性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号